| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2002PNAS...9910042E |
| P356 | DOI | 10.1073/PNAS.142005099 |
| P932 | PMC publication ID | 126621 |
| P698 | PubMed publication ID | 12097641 |
| P5875 | ResearchGate publication ID | 11277716 |
| P2093 | author name string | Ajit Varki | |
| Jamey D Marth | |||
| Lesley G Ellies | |||
| David Ginsburg | |||
| Gallia G Levy | |||
| David Ditto | |||
| Dzung T Le | |||
| Mark Wahrenbrock | |||
| P2860 | cites work | Biochemistry and genetics of von Willebrand factor | Q22003890 |
| Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor | Q24295998 | ||
| The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny | Q24685967 | ||
| Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase | Q28510698 | ||
| Insights from von Willebrand disease animal models | Q28592716 | ||
| The human sialyltransferase family | Q28619925 | ||
| Evolutionary considerations in relating oligosaccharide diversity to biological function | Q33687866 | ||
| God must love galectins; he made so many of them | Q33751857 | ||
| The effect of ABO blood group on the diagnosis of von Willebrand disease. | Q34180946 | ||
| Siglecs, sialic acids and innate immunity | Q34264039 | ||
| Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. | Q34348254 | ||
| Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation | Q34622020 | ||
| O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b | Q35612966 | ||
| Immune regulation by the ST6Gal sialyltransferase | Q36475650 | ||
| Structural characteristics and regulation of the asialoglycoprotein receptor | Q36986346 | ||
| Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets | Q37023086 | ||
| The sialyltransferase "sialylmotif" participates in binding the donor substrate CMP-NeuAc | Q38299599 | ||
| Oligosaccharide valency and conformation in determining binding to the asialoglycoprotein receptor of rat hepatocytes | Q38322765 | ||
| The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. | Q38349688 | ||
| Affinity of four immobilized Erythrina lectins toward various N-linked glycopeptides and related oligosaccharides | Q38350605 | ||
| Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues | Q39623867 | ||
| Von Willebrand's disease: combined qualitative and quantitative abnormalities | Q40644015 | ||
| Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein | Q40651808 | ||
| Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian beta 1,4-galactosyltransferase and alpha 2,6-sialyltransferase genes | Q40826999 | ||
| Selectin ligands, leukocyte trafficking, and fucosyltransferase genes | Q41469716 | ||
| Assay of pyrogens by interleukin-6 release from monocytic cell lines | Q41672713 | ||
| Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures | Q41906702 | ||
| Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants | Q43779260 | ||
| Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis | Q43862863 | ||
| Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor | Q45196383 | ||
| Characterization of the defect of the factor VIII/von Willebrand factor protein in von Willebrand's disease. | Q45864201 | ||
| Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor | Q45883856 | ||
| Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages | Q47206713 | ||
| The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). | Q52852287 | ||
| Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides | Q66943189 | ||
| Phast assessment of vWf:Ag multimeric distribution | Q68598984 | ||
| Galactose-specific receptors on liver cells. II. Characterization of the purified receptor from macrophages reveals no structural relationship to the hepatocyte receptor | Q68944667 | ||
| Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage | Q69044403 | ||
| Branch specificity of bovine colostrum CMP-sialic acid: N-acetyllactosaminide alpha 2----6-sialyltransferase. Interaction with biantennary oligosaccharides and glycopeptides of N-glycosylproteins | Q69881786 | ||
| The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups | Q71381155 | ||
| Galactosyl and N-acetylgalactosaminyl homeostasis: a function for mammalian asialoglycoprotein receptors | Q72767093 | ||
| von Willebrand disease | Q73141668 | ||
| Redefinition of the carbohydrate specificity of Erythrina corallodendron lectin based on solid-phase binding assays and molecular modeling of native and recombinant forms obtained by site-directed mutagenesis | Q73243624 | ||
| High levels of factor VIII and venous thrombosis | Q73434262 | ||
| Comparison of genomic structures of four members of beta-galactoside alpha2,3-sialyltransferase genes in the mouse | Q74000902 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 10042-10047 | |
| P577 | publication date | 2002-07-03 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands | |
| P478 | volume | 99 |
| Q33396841 | A novel type of macrothrombocytopenia associated with a defect in α2,3-sialylation |
| Q33917215 | A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice |
| Q35907051 | ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis |
| Q36604393 | ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? |
| Q36165181 | ASGR1 and ASGR2, the Genes that Encode the Asialoglycoprotein Receptor (Ashwell Receptor), Are Expressed in Peripheral Blood Monocytes and Show Interindividual Differences in Transcript Profile |
| Q41466008 | Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure |
| Q57283092 | Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis |
| Q33694538 | Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation |
| Q40616991 | An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation. |
| Q36268471 | An intrinsic mechanism of secreted protein aging and turnover |
| Q35848737 | Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. |
| Q36120096 | Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity |
| Q37175593 | Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications. |
| Q36182168 | Biosynthesis of the major brain gangliosides GD1a and GT1b |
| Q35752147 | Birth Cohort, Age, and Sex Strongly Modulate Effects of Lipid Risk Alleles Identified in Genome-Wide Association Studies |
| Q39231697 | Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation |
| Q36787433 | Clearance mechanisms of von Willebrand factor and factor VIII. |
| Q38117738 | Clearance of von Willebrand factor. |
| Q36908636 | Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a |
| Q36141826 | Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands |
| Q35159004 | Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication |
| Q35595835 | Dual roles for hepatic lectin receptors in the clearance of chilled platelets |
| Q26851855 | Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities |
| Q91503235 | Exploiting metabolic glycoengineering to advance healthcare |
| Q38922019 | Expression of ST3Gal, ST6Gal, ST6GalNAc and ST8Sia in human hepatic carcinoma cell lines, HepG-2 and SMMC-7721 and normal hepatic cell line, L-02. |
| Q35903416 | Expression of functional P-selectin glycoprotein ligand 1 on hematopoietic progenitors is developmentally regulated |
| Q46133792 | Expression of the sialyltransferase, ST3Gal4, impacts cardiac voltage-gated sodium channel activity, refractory period and ventricular conduction |
| Q38355768 | Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. |
| Q45857734 | Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study |
| Q91675224 | Genetic regulation of plasma von Willebrand factor levels in health and disease |
| Q34674600 | Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists |
| Q35856788 | Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation. |
| Q37027396 | Glycan antagonists and inhibitors: a fount for drug discovery |
| Q37349468 | Glycosylation in immune cell trafficking |
| Q36216763 | Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health |
| Q37998408 | Human deficiencies of fucosylation and sialylation affecting selectin ligands |
| Q33411767 | Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor |
| Q30443305 | Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity |
| Q81412396 | Keeping blood clots at bay in sepsis |
| Q58796525 | Keeping it trim: roles of neuraminidases in CNS function |
| Q38944642 | Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. |
| Q97551370 | Low VWF: insights into pathogenesis, diagnosis, and clinical management |
| Q41512070 | Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels. |
| Q37256125 | Milk oligosaccharide sialyl(α2,3)lactose activates intestinal CD11c+ cells through TLR4 |
| Q34420808 | Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. |
| Q35145883 | Modifier genes and protective alleles in humans and mice |
| Q58761454 | Multiple Roles of Glycans in Hematological Malignancies |
| Q39299024 | N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor. |
| Q35939859 | NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not |
| Q35000878 | Novel and unexpected clearance mechanisms for cold platelets |
| Q33391541 | Novel clearance mechanisms of platelets |
| Q90441308 | Physiological Roles of the von Willebrand Factor-Factor VIII Interaction |
| Q90319311 | Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production |
| Q48362826 | Recurrent infection progressively disables host protection against intestinal inflammation. |
| Q33420790 | Reduced human platelet uptake by pig livers deficient in the asialoglycoprotein receptor 1 protein |
| Q35048797 | Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly |
| Q36951311 | Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications |
| Q33384971 | Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes |
| Q50296348 | ST3GAL4 transfers Neu5Ac to terminal Gal of N-glycans |
| Q35004977 | ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes. |
| Q50296346 | ST6GAL1 transfers Neu5Ac to terminal Gal of N-glycans |
| Q34718297 | ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling |
| Q50296347 | ST8SIA2,3,6 transfer Neu5Ac to terminal Gal of N-glycans |
| Q64094872 | Selectins and Immune Cells in Acute Myocardial Infarction and Post-infarction Ventricular Remodeling: Pathophysiology and Novel Treatments |
| Q35754002 | Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice. |
| Q46215378 | Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells. |
| Q30440648 | Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation |
| Q34737768 | Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases |
| Q24596452 | The Ashwell receptor mitigates the lethal coagulopathy of sepsis |
| Q42917959 | The Ashwell–Morell Receptor |
| Q36187831 | The chemistry and biology of mucin-type O-linked glycosylation |
| Q35149898 | The genetics of common variation affecting platelet development, function and pharmaceutical targeting |
| Q36106312 | The origin and function of platelet glycosyltransferases |
| Q35000830 | The role of lectins and glycans in platelet clearance |
| Q94541441 | The sialyltransferase ST3Gal-IV guides murine T-cell progenitors to the thymus |
| Q33364277 | The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents |
| Q43153236 | Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implications |
| Q38796983 | What Have We Learned from Glycosyltransferase Knockouts in Mice? |
| Q41228470 | α(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis |
| Q57445739 | α2,3-Sialyltransferase-IV is essential for L-selectin ligand function in inflammation |
Search more.